Literature DB >> 24493488

Canagliflozin.

René Rodríguez-Gutiérrez1, Gloria Gonzalez-Saldivar.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24493488     DOI： 10.3949/ccjm.81c.02003

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN： 0891-1150            Impact factor:   2.321


× No keyword cloud information.
  7 in total

Review 1.  Short commentary on empagliflozin and its potential clinical impact.

Authors:  Deborah Hinnen
Journal:  Ther Adv Endocrinol Metab       Date:  2015-04       Impact factor: 3.565

2.  Mechanism of Increased LDL (Low-Density Lipoprotein) and Decreased Triglycerides With SGLT2 (Sodium-Glucose Cotransporter 2) Inhibition.

Authors:  Debapriya Basu; Lesley-Ann Huggins; Diego Scerbo; Joseph Obunike; Adam E Mullick; Paul L Rothenberg; Nicholas A Di Prospero; Robert H Eckel; Ira J Goldberg
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-09       Impact factor: 8.311

Review 3.  The potential role of sodium glucose co-transporter 2 inhibitors in the early treatment of type 2 diabetes mellitus.

Authors:  S A Brunton
Journal:  Int J Clin Pract       Date:  2015-07-05       Impact factor: 2.503

Review 4.  Sodium-glucose co-transporter 2 inhibitors for type 2 diabetes mellitus: An overview for the primary care physician.

Authors:  Paresh Dandona; Ajay Chaudhuri
Journal:  Int J Clin Pract       Date:  2017-04-24       Impact factor: 2.503

5.  A comparison of effects of DPP-4 inhibitor and SGLT2 inhibitor on lipid profile in patients with type 2 diabetes.

Authors:  Seon-Ah Cha; Yong-Moon Park; Jae-Seung Yun; Tae-Seok Lim; Ki-Ho Song; Ki-Dong Yoo; Yu-Bae Ahn; Seung-Hyun Ko
Journal:  Lipids Health Dis       Date:  2017-04-13       Impact factor: 3.876

Review 6.  The Effects of SGLT2 Inhibitors on Lipid Metabolism.

Authors:  Zsolt Szekeres; Kalman Toth; Eszter Szabados
Journal:  Metabolites       Date:  2021-02-01

Review 7.  Update on developments with SGLT2 inhibitors in the management of type 2 diabetes.

Authors:  Michael A Nauck
Journal:  Drug Des Devel Ther       Date:  2014-09-11       Impact factor: 4.162
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.